Sleep regulation: A bidirectional interaction between brain and the endocrine system

Clinical Neuropsychiatry

Volumn 8, Issue 3, 2011, Pages 192-203

  Marano, Giuseppe ^a   Traversi, Gianandrea ^a   Catalano, Valeria ^a   Dittoni, Serena ^a   Marca, Giacomo Delia ^a   Mazza, Salvatore ^a   Mazza, Marianna ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

EEG; Hormones; Hypothalamic pituitary adrenal axis; Nervous system; Neuroendocrinology; Sleep

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR;

AGING; BRAIN; CIRCADIAN RHYTHM; ENDOCRINE SYSTEM; GABAERGIC SYSTEM; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANCY; INSOMNIA; NERVOUS SYSTEM FUNCTION; NEUROANATOMY; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; REGULATORY MECHANISM; REM SLEEP; REVIEW; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDER; SLEEP REGULATION;

EID: 79960069781     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. th Washington.
2. Anders T, Emde R, Parmelae A (1971). Manual of standardized terminology, techniques, and criteria for scoring of states of sleep and wakefulness in newborn infants. CA: UCLA Brain Information Service/NINDS Neurological Information Network, Los Angeles.
3. Antonijevic IA, Murck H, Frieboes R, Holsboer F, Steiger A (1999). On the gender differences in sleep-endocrine regulation in young normal humans. Neuroendocrinology 70, 4, 280-287.
4. Antonijevic IA, Murck H, Frieboes RM, Barthelmes J, Steiger A (2000a). Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls-part I: the sleep eeg. Sleep research online: SRO 3, 1, 5-13.
5. Antonijevic IA, Stalla GK, Steiger A (2000b). Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. American journal of obstetrics and gynecology 182, 2, 277-282.
6. Antonijevic IA, Murck H, Bohlhalter S, Frieboes RM, Holsboer F, Steiger A (2000c). Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39, 8, 1474-1481.
7. Antonijevic IA, Murck H, Frieboes RM, Uhr M, Steiger A (2003). On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendo-crinology 28, 3, 401-418.
8. Ardura J, Gutierrez R, Andres J, Agapito T (2003). Emergence and evolution of the circadian rhythm of melatonin in children. Hormone research 59, 2, 66-72.
9. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E (2001). Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. The Journal of clinical endocrinology and metabolism 86, 3, 1169-1174.
10. Bertler A (1961). Occurrence and localization of catecholamines in the human brain. Acta physiologica Scandinavica 51, 97-107.
11. Blalock JE (1994). Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Annals of the New York Academy of Sciences 25, 741, 292-298.
12. Bohlhalter S, Murck H, Holsboer F, Steiger A (1997). Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects. Neurobiology of Aging 18, 4, 423-429.
13. Borbely AA, Tobler I (1989). Endogenous sleep-promoting substances and sleep regulation. Pharmacological reviews 69, 2, 605-670.
14. Breen S, Rees S, Walker D (1996). The development of diurnal rhythmicity in fetal suprachiasmatic neurons as demonstrated by fos immunohistochemistry. Neuroscience 74, 3, 917-926.
15. Bremner WJ, Vitiello MV, Prinz PN (1983). Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. The Journal of clinical endocrinology and metabolism 56, 6, 1278-1281.
16. Brunner DP, Münch M, Biedermann K, Huch R, Huch A, Borbély AA (1994). Changes in sleep and sleep electroencephalogram during pregnancy. Sleep 17, 7, 576-582.
17. Buckley TM, Schatzberg AF (2005). On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. The Journal of clinical endocrinology and metabolism 90, 5, 3106-3114.
18. Burgos I, Richter L, Klein T, Fiebich B, Feige B, Lieb K, Voderholzer U, Riemann D (2006). Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain, behavior, and immunity 20, 3, 246-253.
19. Chrousos GP (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. The New England journal of medicine 332, 20, 1351-1362.
20. Culebras A (2000). Sleep disorders and neurological disease. Marcel Dekker, Inc. New York.
21. Dantzer R (2004). Innate immunity at the forefront of psychoneuroimmunology. Brain, behavior, and immunity 18, 1, 1-6.
22. Datta S, Hobson JA (1995). Suppression of ponto-geniculooccipital waves by neurotoxic lesions of pontine caudolateral peribrachial cells. Neuroscience 67, 3, 703-712.
23. Datta S, Maclean RR (2007). Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neuroscience and biobehavioral reviews 31, 5, 775-824.
24. Datta S, Patterson EH, Siwek DF (1997). Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep. Synapse 27, 1, 69-78.
25. Dayal M, Sammel MD, Zhao J, Hummel AC, Vandenbourne K, Barnhart KT (2005). Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. Journal of women's health 14, 5, 391-400.
26. de Lecea L (2005). Cortistatin: a natural somatostatin analog. Journal of endocrinological investigation 28, 11, 10-14.
27. de Lecea L, Bourgin P (2008). Neuropeptide interactions and REM sleep: a role for Urotensin II? Peptides 29, 5, 845-851.
28. Driver HS, Shapiro CM (1992). A longitudinal study of sleep stages in young women during pregnancy and postpartum. Sleep 15, 5, 449-453.
29. Drucker-Colín R, Aguilar-Roblero R, García-Hernández F, Fernández-Cancino F, Bermudez Rattoni F (1984). Fetal suprachiasmatic nucleus transplants: diurnal rhythm recovery of lesioned rats. Brain research 311, 2, 353-357.
30. Ehlers CL, Kupfer DJ (1997). Slow-wave sleep: do young adult men and women age differently? Journal of sleep research 6, 3, 211-215.
31. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000). The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacological reviews 52, 4, 595-638.
32. Fehm HL, Späth-Schwalbe E, Pietrowsky R, Kern W, Born J (1993). Entrainment of nocturnal pituitary-adrenocortical activity to sleep processes in man-a hypothesis. Experimental and Clinical Endocrinology 101, 5, 267-276.
33. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S (1987). Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunological reviews 100, 225-260.
34. Ferrari E, Magri F, Locatelli M, Balza G, Nescis T, Battegazzore C, Cuzzoni G, Fioravanti M, Solerte SB (1996). Chrononeuroendocrine markers of the aging brain. Aging (Milano) 8, 5, 320-327.
35. Ficca G, Fagioli I, Salzarulo P (2000). Sleep organization in the first year of life: developmental trends in the quiet sleepparadoxical sleep cycle. Journal of sleep research 9, 1, 1-4.
36. Frieboes RM, Murck H, Schier T, Holsboer F, Steiger A (1997). Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 16, 5, 339-345.
37. Frieboes RM, Murck H, Stalla GK, Antonijevic IA, Steiger A (1998). Enhanced slow wave sleep in patients with prolactinoma. The journal of clinical endocrinology and metabolism 83, 8, 2706-10.
38. Friess E, Tagaya H, Grethe C, Trachsel L, Holsboer F (2004). Acute cortisol administration promotes sleep intensity in man. Neuropsychopharmacology 29, 3, 598-604.
39. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F (1995)a. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. American Journal of Physiology 268, 1, 107-113.
40. Friess E, V Bardeleben U, Wiedemann K, Lauer CJ, Holsboer F (1994). Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. Journal of Sleep Research 3, 2, 73-79.
41. Friess E, Wiedemann K, Steiger A, Holsboer F (1995)b. The hypothalamic-pituitary-adrenocortical system and sleep in man. Advances in neuroimmunology 5, 2, 111-125.
42. Fuller PM, Gooley JJ, Saper CB (2006). Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. Journal of biological rhythms 21, 6, 482-493.
43. Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S (2009). Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 17, 2, 166-169.
44. Guldner J, Schier T, Friess E, Colla M, Holsboer F, Steiger A (1997). Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiology of Aging 18, 5, 491-495.
45. 2 and Adenosine. In Luppi PH (ed) Sleep circuits and functions. Boca Raton, pp. 65-79.
46. Hayaishi O, Matsumura H (1995). Prostaglandins and sleep. Advances in neuroimmunology 5, 2, 211-216.
47. Held K, Antonijevic I, Murck H, Kuenzel H, Steiger A (2006). Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 31, 1, 100-107.
48. Hemmeter U, Rothe B, Guldner J, Holsboer F, Steiger A (1998). Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers. Neuropsychobiology 38, 1, 25-31.
49. Heraghty JL, Hilliard TN, Henderson AJ, Fleming PJ (2008). The physiology of sleep in infants. Archives of disease in childhood 93, 11, 982-5.
50. Hertz G, Fast A, Feinsilver SH, Albertario CL, Schulman H, Fein AM (1992). Sleep in normal late pregnancy. Sleep 15, 3, 246-251.
51. Holsboer F, von Bardeleben U, Steiger A (1988). Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48, 1, 32-38.
52. Huang ZL, Urade Y, Hayaishi O (2011). The role of adenosine in the regulation of sleep. Current topics in medicinal chemistry 11, 8, 1047-1057.
53. Inoue S (1989). Biology of Sleep Substances. CRC Press, Boca Raton.
54. Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M (2003). Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain, behavior, and immunity 17, 5, 365-372.
55. Jackson JA, Wailoo MP, Thompson JR, Petersen SA (2004). Early physiological development of infants with intrauterine growth retardation. Archives of disease in childhood, Fetal and neonatal edition 89, 1, 46-50.
56. Jan JE, Wasdell MB, Freeman RD, Bax M (2007). Evidence supporting the use of melatonin in short gestation infants. Journal of pineal research 42, 1, 22-27.
57. Jiang CL, Lu CL, Liu XY (1998). The molecular basis for bidirectional communication between the immune and neuroendocrine systems. Domestic animal endocrinology 15, 5, 363-369.
58. Keller-Wood ME, Dallman MF (1984). Corticosteroid inhibition of ACTH secretion. Endocrine reviews 5, 1, 1-24.
59. Kennaway DJ, Stamp GE, Goble FC (1992). Development of melatonin production in infants and the impact of prematurity. The Journal of clinical endocrinology and metabolism 75, 2, 367-369.
60. Kilduff TS, Lein ES, de la Iglesia H, Sakurai T, Fu YH, Shaw P (2008). New developments in sleep research: molecular genetics, gene expression, and systems neurobiology. The Journal of Neuroscience 28, 46, 11814-11818.
61. Kimura M (2005). Minireview: Gender-specific sleep regulation. Sleep and Biological Rhythms 3, 2, 75-79.
62. Kotronoulas G, Stamatakis A, Stylianopoulou F (2009). Hormones, hormonal agents, and neuropeptides involved in the neuroendocrine regulation of sleep in humans. Hormones 8, 4, 232-248.
63. Krueger JM, Fang J, Hansen MK, Zhang J, Obál F Jr (1998). Humoral Regulation of Sleep. News in physiological sciences: an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society 13, 189-194.
64. Krueger JM, Majde JA (1994). Microbial products and cytokines in sleep and fever regulation. Critical reviews in immunology 14, 3-4, 355-379.
65. Krueger JM, Obál F Jr (1993). Growth hormone-releasing hormone and interleukin-1 in sleep regulation. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 7, 8, 645-652.
66. Kubota K (1989). Kuniomi Ishimori and the first discovery of sleep-inducing substances in the brain. Neuroscience research 6, 6, 497-518.
67. Lai Z, Roos P, Zhai O, Olsson Y, Fhölenhag K, Larsson C, Nyberg F (1993). Age-related reduction of human growth hormone-binding sites in the human brain. Brain research 621, 2, 260-266.
68. Lancel M, Faulhaber J, Holsboer F, Rupprecht R (1999). The GABA(A) receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone. Psychopharmacology 141, 2, 213-9.
69. Lowrey PL, Takahashi JS (2004). Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annual review of genomics and human genetics 5, 407-41.
70. Lu J, Sherman D, Devor M, Saper CB (2006). A putative flip-flop switch for control of REM sleep. Nature 441, 7093, 589-594.
71. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meaney MJ (1994). Basal cortisol levels and cognitive deficits in human aging. The Journal of neuroscience: the official journal of the Society for Neuroscience 14, 5, 2893-2903.
72. Majde JA, Krueger JM (2005). Links between the innate immune system and sleep. The Journal of allergy and clinical immunology 116, 6, 1188-1198.
73. Marshall L, Mölle M, Böschen G, Steiger A, Fehm HL, Born J (1996). Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). The Journal of clinical endocrinology and metabolism 81, 3, 1009-1013.
74. McCarley RW (2004). Mechanisms and models of REM sleep control. Archives italiennes de biologie 142, 4, 429-467.
75. Moore RY, Eichler VB (1972). Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain research 42, 1, 201-206.
76. Murck H, Antonijevic IA, Frieboes RM, Maier P, Schier T, Steiger A (1999). Galanin has REM-sleep deprivation-like effects on the sleep EEG in healthy young men. Journal of psychiatric research 33, 3, 225-232.
77. Murck H, Guldner J, Colla-Müller M, Frieboes RM, Schier T, Wiedemann K, Holsboer F, Steiger A (1996). VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. The American journal of physiology 271, 4, 905-911.
78. Murck H, Held K, Ziegenbein M, Künzel H, Holsboer F, Steiger A (2004). Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29, 9, 1205-1211.
79. Nishihara K, Horiuchi S, Eto H, Uchida S, Honda M (2004). Delta and theta power spectra of night sleep EEG are higher in breast-feeding mothers than in non-pregnant women. Neuroscience letters 368, 2, 216-220.
80. Nishino S (2003). The hypocretin/orexin system in health and disease. Biological psychiatry 54, 2, 87-95.
81. Nishino S (2007). The hypocretin/orexin receptor: therapeutic prospective in sleep disorders. Expert opinion on investigational drugs 16, 11, 1785-1797.
82. Nishino S, Arrigoni J, Shelton J, Kanbayashi T, Dement WC, Mignot E (1997). Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. The Journal of neuroscience: the official journal of the Society for Neuroscience 17, 16, 6401-6408.
83. Obál F Jr., Krueger JM (2001). The somatotropic axis and sleep. Revue neurologique 157, 11, 12-15.
84. Perras B, Pannenborg H, Marshall L, Pietrowsky R, Born J, Lorenz Fehm H (1999). Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin. Journal of Clinical Psychopharmacology 19, 1, 28-36.
85. Polo-Kantola P, Erkkola R, Helenius H, Irjala K, Polo O (1998). When does estrogen replacement therapy improve sleep quality? American journal of obstetrics and gynecology 178, 5, 1002-1009.
86. Prosser RA, Gillette MU (1989). The mammalian circadian clock in the suprachiasmatic nuclei is reset in vitro by cAMP. The Journal of neuroscience: the official journal of the Society for Neuroscience 9, 3, 1073-1081.
87. Ralph MR, Foster RG, Davis FC, Menaker M (1990). Transplanted suprachiasmatic nucleus determines circadian period. Science 247, 4945, 975-978.
88. Rehman HU, Masson EA (2001). Neuroendocrinology of ageing. Age and Ageing 30, 4, 279-287.
89. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D (1995). A review of the evidence supporting melatonin's role as an antioxidant. Journal of pineal research 18, 1, 1-11.
90. Rétey JV, Adam M, Honegger E, Khatami R, Luhmann UF, Jung HH, Berger W, Landolt HP (2005). A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proceedings of the National Academy of Sciences of the United States of America 102, 43, 15676-15681.
91. Reul JM, Holsboer F (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Current opinion in pharmacology 2, 1, 23-33.
92. Riemann D, Kloepfer C, Berger M (2009). Functional and structural brain alterations in insomnia: implications for pathophysiology. European Journal of Neuroscience 29, 9, 1754-1760.
93. Rivkees SA (2003). Developing circadian rhythmicity in infants. Pediatrics 112, 2, 373-381.
94. Rodenbeck A, Hajak G (2001). Neuroendocrine dysregulation in primary insomnia. Revue neurologique 157, 11, 57-61.
95. Rodenbeck A, Huether G, Rüther E, Hajak G (2002). Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neuroscience letters 324, 2, 159-163.
96. Roky R, Obál F Jr, Valatx JL, Bredow S, Fang J, Pagano LP, Krueger JM (1995). Prolactin and rapid eye movement sleep regulation. Sleep 18, 7, 536-542.
97. Romanowski CP, Fenzl T, Flachskamm C, Wurst W, Holsboer F, Deussing JM, Kimura M (2010). Central deficiency of corticotropin-releasing hormone receptor type 1 (CRH-R1) abolishes effects of CRH on NREM but not on REM sleep in mice. Sleep 33, 4, 427-436.
98. Rossmanith WG, Reichelt C, Scherbaum WA (1994). Neuroendocrinology of aging in humans: attenuated sensitivity to sex steroid feedback in elderly postmenopausal women. Neuroendocrinology 59, 4, 355-362.
99. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA: the journal of the American Medical Association 288, 3, 321-333.
100. Santiago LB, Jorge SM, Moreira AC (1996). Longitudinal evaluation of the development of salivary cortisol circadian rhythm in infancy. Clinical Endocrinology 44, 2, 157-161.
101. Sapolsky RM, Romero LM, Munck AU (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine reviews 21, 1, 55-89.
102. Shin K, Shapiro C (2003). Menopause, sex hormones, and sleep. Bipolar disorders 5, 2, 106-109.
103. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C (1997). Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. The Journal of clinical endocrinology and metabolism 82, 6, 1661-1667.
104. Spiegel K, Leproult R, Van Cauter E (1999). Impact of sleep debt on metabolic and endocrine function. Lancet 354, 9188, 1435-1439.
105. Spinedi E, Gaillard RC, Chisari A (2002). Sexual dimorphism of neuroendocrine-immune interactions. in: Neuroendocrine-Immune Interactions. Karger, Basel.
106. Steiger A (2002). Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Medicine Reviews 6, 2, 125-138.
107. Steiger A (2003). Sleep and endocrinology. Journal of Internal Medicine 254, 1, 13-22.
108. Steiger A (2007). Neurochemical regulation of sleep. Journal of psychiatric research 41, 7, 537-52.
109. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F (1992). Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56, 4, 566-573.
110. Stephan FK, Zucker I (1972). Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proceedings of the National Academy of Sciences of the United States of America 69, 6, 1583-1586.
111. Steriade M, McCarley RW (1990). Brainstem Control of Wakefulness and Sleep. Plenum Press, New York.
112. Takahashi Y, Kipnis DM, Daughaday WH (1968). Growth hormone secretion during sleep. The Journal of clinical investigation 47, 9, 2079-2090.
113. Taylor MM, Samson WK (2003). The other side of the orexins: endocrine and metabolic actions. American journal of physiology, Endocrinology and metabolism 284, 1, 13-7.
114. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ (1987). The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. The Journal of clinical endocrinology and metabolism 65, 6, 1118-1126.
115. Tenovr JS (1992). Effects of testosterone supplementation in the aging male. The Journal of clinical endocrinology and metabolism 75, 4, 1092-1098.
116. Thakkar MM, Engemann SC, Walsh KM, Sahota PK (2008). Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 153, 4, 875-880.
117. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptácek LJ, Fu YH (2001). An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291, 5506, 1040-1043.
118. Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, Kloiber S, Salyakina D, Thoeringer CK, Kern N, Lieb R, Uhr M, Binder EB, Müller-Myhsok B, Holsboer F, Keck ME (2008). Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of affective disorders 105, 1-3, 177-184.
119. Van Cauter E, Plat L, Copinschi G (1998). Interrelations between sleep and the somatotropic axis. Sleep 21, 6, 553-566.
120. van den Heuvel CJ, Ferguson SA, Macchi MM, Dawson D (2005). Melatonin as a hypnotic: con. Sleep medicine reviews 9, 1, 71-80.
121. van West D, Del-Favero J, Aulchenko Y, Oswald P, Souery D, Forsgren T, Sluijs S, Bel-Kacem S, Adolfsson R, Mendlewicz J, Van Duijn C, Deboutte D, Van Broeckhoven C, Claes S (2004). A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Molecular psychiatry 9, 3, 287-292.
122. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP (2001a). Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. The Journal of clinical endocrinology and metabolism 86, 8, 3787-3794.
123. Vgontzas AN, Bixler EO, Wittman AM, Zachman K, Lin HM, Vela-Bueno A, Kales A, Chrousos GP (2001b). Middleaged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications. The Journal of clinical endocrinology and metabolism 86, 4, 1489-1495.
124. Vgontzas AN, Chrousos GP (2002). Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinology and metabolism clinics of North America 31, 1, 15-36.
125. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP (1999). Circadian interleukin-6 secretion and quantity and depth of sleep. The Journal of clinical endocrinology and metabolism 84, 8, 2603-2607.
126. Wade A, Downie S (2008). Prolonged-release melatonin for the treatment of insomnia in patients over 55 years. Expert opinion on investigational drugs 17, 10, 1567-1572.
127. Watson CJ, Soto-Calderon H, Lydic R, Baghdoyan HA (2008). Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 31, 4, 453-464.
128. Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A (2003). Ghrelin promotes slow-wave sleep in humans. American journal of physiology. Endocrinology and metabolism 284, 2, 407-415.
129. Weitzman ED, Schaumburg H, Fishbein W (1966). Plasma 17-hydroxycorticosteroid levels during sleep in man. The Journal of clinical endocrinology and metabolism 26, 2, 121-127.
130. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, Kjellmer I, Mallard C (2007). Melatonin reduces inflammation and cell death in white matter in the midgestation fetal sheep following umbilical cord occlusion. Pediatric research 61, 2, 153-158.
131. Wiklund I, Karlberg J, Mattsson LA (1993). Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. American journal of obstetrics and gynecology 168, 3, 824-830.
132. Wilson MA (1992). Influences of gender, gonadectomy, and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain research bulletin 29, 2, 165-172.
133. Wrona D (2006). Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. Journal of neuroimmunology 172, 1-2, 38-58.
134. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptácek LJ, Fu YH (2005). Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434, 7033, 640-644.
135. Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptácek LJ (2007). Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 128, 1, 59-70.
136. Zhdanova IV (2005). Melatonin as a hypnotic: pro. Sleep medi-cine reviews 9, 1, 51-65.
137. Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ (1996). Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep 19, 5, 423-431.
138. Ziemssen T, Kern S (2007). Psychoneuroimmunology-cross-talk between the immune and nervous systems. Journal of neurology 254, 2, I8-11.
139. Zumoff B, Strain GW, Kream J, O'Connor J, Rosenfeld RS, Levin J, Fukushima DK (1982). Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men. The Journal of clinical endocrinology and metabolism 54, 3, 534-538.